Folded conformations due to arene interactions in dissymmetric and symmetric butylidene‐linker models based on pyrazolo[3,4‐d]pyrimidine,purine and 7‐deazapurine

The butylidene‐linker models 1‐[2‐(2,6‐dimethylsulfanyl‐9H‐purin‐9‐yl)‐2‐methylidenepropyl]‐4,6‐bis(methylsulfanyl)‐1H‐pyrazolo[3,4‐d]pyrimidine, C₁₈H₂₀N₈S₄, (XI), 7,7′‐(2‐methylidenepropane‐1,3‐diyl)bis[3‐methyl‐2‐methylsulfanyl‐3H‐pyrrolo[2,3‐d]pyrimidin‐4(7H)‐one], C₂₀H₂₂N₆O₂S₂, (XIV), and 7‐[2‐(4,6‐dimethylsulfanyl‐1H‐pyrazolo[3,4‐d]pyrimidin‐1‐yl)‐2‐methylidenepropyl]‐3‐methyl‐2‐methylsulfanyl‐3H‐pyrrolo[2,3‐d]pyrimidin‐4(7H)‐one, C₁₉H₂₁N₇OS₃, (XV), show folded conformations in solution, as shown by ¹H NMR analysis. This folding carries over to the crystalline state. Intramolecular π–π interactions are observed in all three compounds, but only (XIV) shows additional intramolecular C—H...π interactions in the solid state. As far as can be established, this is the first report incorporating the pyrrolo[2,3‐d]pyrimidine nucleus for such a study. In addition to the π–π interactions, the crystal structures are also stabilized by other weak intermolecular C—H...S/N/O and/or S...N/S interactions.     

A Catalyst‐Free Aqueous Synthesis of 2‐Amino‐7,9‐dihydrothieno[3′,2′:5,6]pyrido[2,3‐d]pyrimidine‐4,6(3H,5H)‐dione Derivatives

A series of novel 7,9‐dihydrothieno[3′,2′:5,6]pyrido[2,3‐d]pyrimidine‐4,6(3H,5H)‐dione derivatives were synthesized efficiently via the catalyst‐free reaction of aldehyde, ethyl 2,4‐dioxotetrahydrothiophene‐3‐carboxylate, and 2,6‐diaminopyrimidine‐4(3H)‐one through the sequence of deethoxycarbonylation and three‐component condensation in aqueous media. This protocol featured mild reaction conditions, high yields, easy work‐up, and environmentally friendly procedure.     

Addition Reactions of Me3SiCN with Aldehydes Catalyzed by Aluminum Complexes Containing in their Coordination Sphere O,S, and N Ligands

The reaction of one equivalent of LAlH₂ ( 1 ; L=HC(CMeNAr)₂, Ar=2,6‐iPr₂C₆H₃, β‐diketiminate ligand) with two equivalents of 2‐mercapto‐4,6‐dimethylpyrimidine hydrate resulted in LAl[(μ‐S)(m‐C₄N₂H)(CH₂)₂]₂ ( 2 ) in good yield. Similarly, when N‐2‐pyridylsalicylideneamine, N‐(2,6‐diisopropylphenyl)salicylaldimine, and ethyl 3‐amino‐4,5,6,7‐tetrahydrobenzo[b]thiophene‐2‐carboxylate were used as starting materials, the corresponding products LAl[(μ‐O)(o‐C₆H₄)CN(C₅NH₄)]₂ ( 3 ), LAlH[(μ‐O)(o‐C₄H₄)CN(2,6‐iPr₂C₆H₃)] ( 4 ), and LAl[(μ‐NH)(o‐C₈SH₈)(COOC₂H₅)]₂ ( 5 ) were isolated. Compounds 2 – 5 were characterized by ¹H and ¹³C NMR spectroscopy as well as by single‐crystal X‐ray structural analysis. Surprisingly, compounds 2 – 5 exhibit good catalytic activity in addition reactions of aldehydes with trimethylsilyl cyanide (TMSCN).     

Synthesis of (Methyl 3‐O‐Benzyl‐4,6‐O‐benzylidene‐2‐deoxy‐α‐d‐altropyranosid‐2‐yl)thiophene Derivatives as Precursors of New Iso‐C‐nucleoside Analogues

Treatment of 2‐(methyl 3‐O‐benzyl‐4,6‐O‐benzylidene‐2‐deoxy‐α‐d‐altropyranosid‐2‐yl)ethanal (3) with malononitrile in the presence of aluminium oxide provided 2‐cyano‐4‐(methyl 3‐O‐benzyl‐4,6‐O‐benzylidene‐2‐deoxy‐α‐d‐altropyranosid‐2‐yl)crotononitrile (4). Starting from 4, cyclization with sulphur and triethylamine yielded 2‐amino‐5‐(methyl 3‐O‐benzyl‐4,6‐O‐benzylidene‐2‐deoxy‐α‐d‐altropyranosid‐2‐yl)thiophene‐3‐carbonitrile (5). Further cyclization could be achieved with triethyl orthoformate/ammonia to furnish 4‐amino‐6‐(methyl 3‐O‐benzyl‐4,6‐O‐benzylidene‐2‐deoxy‐α‐d‐altropyranosid‐2‐yl)thieno[2.3‐d]pyrimidine (8).     

Keggin Heteropolyacid Catalyzed Synthesis of Isoxazolo[5,4-d]pyrimidine-4,6(5H,7H)-diones at Room Temperature

Isoxazolo[5,4‐d]pyrimidine‐4,6(5H,7H)diones 2a – 2f have been synthesized from the reaction of ethyl 5‐amino‐3‐methyl‐4‐isoxazole carboxylate ( 1 ) with aryl isocyanates in the presence of Keggin heteropolyacid H₃[PW₁₂O₄₀] as a green solid acid catalyst at room temperature in a one‐pot process in good yields.     

Disappearance of intramolecular stacking due to one‐atom movement or increment of a `propyl­ene linker' in pyrazolo­[3,4‐d]­pyrimidine‐based ­flexible models

In the crystal structures of 4,6‐di­methyl­thio‐1‐[3‐(4,6‐di­methyl­thio‐2H‐pyra­zolo­[3,4‐d]­py­rimi­din‐2‐yl)­propyl]‐1H‐py­ra­­zolo­[3,4‐d]­py­rimi­dine, C₁₇H₂₀N₈S₄, and 1‐[4‐(4‐meth­oxy‐6‐methyl­thio‐1H‐pyra­zolo­[3,4‐d]py­rimi­din‐1‐yl)­butyl]‐5‐meth­yl‐6‐methyl­thio‐4,5‐di­hydro‐1H‐pyra­zolo­[3,4‐d]py­rimi­din‐4‐one, C₁₈H₂₂N₈O₂S₂, only intermolecular stacking due to aromatic π–π interactions between pyrazolo­[3,4‐d]­pyrimidinerings is present.     

Synthesis of a Blocked Tetrasaccharide Related to the Repeating Unit of the Antigen from Shigella dysenteriae Type 9 in the Form of Its Methyl (R)‐Pyruvate Ester and 2‐(Trimethylsilyl)Ethyl Glycoside

Starting from d‐mannose, d‐galactose and d‐glucosamine hydrochloride, two disaccharide blocks were synthesized. Schmidt's inverse addition technique of trichloroacetimidate was utilized for the construction of a disaccharide with a β‐mannosidic linkage in good yield. The other disaccharide had a methyl 4,6‐(R)‐pyruvate ester. The two disaccharides in the appropriate form were then allowed to react in the presence of N‐iodosuccinimide (NIS) and trifluoromethanesulfonic acid (TfOH) to give the desired tetrasaccharide derivative, 2‐(trimethylsilyl)ethyl 2‐acetamido‐3,4,6‐tri‐O‐benzoyl‐2‐deoxy‐β‐d‐glucopyranosyl‐(1→3)‐2‐O‐benzoyl‐4,6‐O‐[(R)‐1‐methoxycarbonylethylidene]‐β‐d‐galactopyranosyl‐(l→4)‐2,3,6‐tri‐O‐benzyl‐β‐d‐mannopyranosyl‐(1→4)‐2,6‐di‐O‐benzyl‐3‐O‐(4‐methoxybenzyl)‐β‐d‐galactopyranoside.     

From Dibismuthenes to Three‐ and Two‐Coordinated Bismuthinidenes by Fine Ligand Tuning: Evidence for Aromatic BiC3N Rings through a Combined Experimental and Theoretical Study

The reduction of N,C,N‐chelated bismuth chlorides [C₆H₃‐2,6‐(CH?NR)₂]BiCl₂ [where R=tBu ( 1 ), 2′,6′‐Me₂C₆H₃ ( 2 ), or 4′‐Me₂NC₆H₄ ( 3 )] or N,C‐chelated analogues [C₆H₂‐2‐(CH?N‐2′,6′‐iPr₂C₆H₃)‐4,6‐(tBu)₂]BiCl₂ ( 4 ) and [C₆H₂‐2‐(CH₂NEt₂)‐4,6‐(tBu)₂]BiCl₂ ( 5 ) is reported. Reduction of compounds 1 – 3 gave monomeric N,C,N‐chelated bismuthinidenes [C₆H₃‐2,6‐(CH?NR)₂]Bi [where R=tBu ( 6 ), 2′,6′‐Me₂C₆H₃ ( 7 ) or 4′‐Me₂NC₆H₄ ( 8 )]. Similarly, the reduction of 4 led to the isolation of the compound [C₆H₂‐2‐(CH?N‐2′,6′‐iPr₂C₆H₃)‐4,6‐(tBu)₂]Bi ( 9 ) as an unprecedented two‐coordinated bismuthinidene that has been structurally characterized. In contrast, the dibismuthene {[C₆H₂‐2‐(CH₂NEt₂)‐4,6‐(tBu)₂]Bi}₂ ( 10 ) was obtained by the reduction of 5 . Compounds 6 – 10 were characterized by using ¹H and ¹³C NMR spectroscopy and their structures, except for 7 , were determined with the help of single‐crystal X‐ray diffraction analysis. It is clear that the structure of the reduced products (bismuthinidene versus dibismuthene) is ligand‐dependent and particularly influenced by the strength of the N→Bi intramolecular interaction(s). Therefore, a theoretical survey describing the bonding situation in the studied compounds and related bismuth(I) systems is included. Importantly, we found that the C₃NBi chelating ring in the two‐coordinated bismuthinidene 9 exhibits significant aromatic character by delocalization of the bismuth lone pair.     

Bromodimethylsulfonium Bromide Catalyzed Synthesis of Methyl 2‐Dexoy‐4,6‐O‐benzylidene Galactopyranoside from Galactal and the Rapid Route to 2,3‐ and 2,6‐Dideoxygalactopyranoses

4,6‐O‐Benzylidenation of D‐galactal with PhCH(OCH₃)₂ catalyzed by bromodimethylsulfonium bromide leads to methyl 2‐dexoy‐4,6‐O‐benzylidene galactopyranoside efficiently, which serves as a key intermediate to the ready preparation of 2,3‐ and 2,6‐dideoxy galactopyranosides.     

Direct Synthesis of Titanium Complexes with Chelating cis‐9,10‐Dihydrophenanthrenediamide Ligands through Sequential C?C Bond‐Forming Reactions from o‐Metalated Arylimines

A series of new titanium(IV) complexes with o‐metalated arylimine and/or cis‐9,10‐dihydrophenanthrenediamide ligands, [o‐C₆H₄(CH?NR)TiCl₃] (R=2,6‐iPr₂C₆H₃ ( 3 a ), 2,6‐Me₂C₆H₃ ( 3 b ), tBu ( 3 c )), [cis‐9,10‐PhenH₂(NR)₂TiCl₂] (PhenH₂=9,10‐dihydrophenanthrene; R=2,6‐iPr₂C₆H₃ ( 4 a ), 2,6‐Me₂C₆H₃ ( 4 b ), tBu ( 4 c )), [{cis‐9,10‐PhenH₂(NR)₂}{o‐C₆H₄(HC?NR)}TiCl] (R=2,6‐iPr₂C₆H₃ ( 5 a ), 2,6‐Me₂C₆H₃ ( 5 b ), tBu ( 5 c )), have been synthesised from the reactions of TiCl₄ with o‐C₆H₄(CH?NR)Li (R=2,6‐iPr₂C₆H₃, 2,6‐Me₂C₆H₃, tBu). Complexes 4 and 5 were formed unexpectedly from the reactions of TiCl₄ with two or three equivalents of the corresponding o‐C₆H₄(CH?NR)Li followed by sequential intramolecular C? C bond‐forming reductive elimination and oxidative coupling reactions. Attempts to isolate the intermediates, [{o‐C₆H₄(CH?NR)}₂TiCl₂] ( 2 ), were unsuccessful. All complexes were characterised by ¹H and ¹³C NMR spectroscopy, and the molecular structures of 3 a , 4 a – c , 5 a , and 5 c were determined by X‐ray crystallography.     

Differentiation of isomeric dinitrotoluenes and aminodinitrotoluenes using electrospray high resolution mass spectrometry

Explosive detection and identification play an important role in the environmental and forensic sciences. However, accurate identification of isomeric compounds remains a challenging task for current analytical methods. The combination of electrospray multistage mass spectrometry (ESI‐MSⁿ) and high resolution mass spectrometry (HRMS) is a powerful tool for the structure characterization of isomeric compounds. We show herein that resonant ion activation performed in a linear quadrupole ion trap allows the differentiation of dinitrotoluene isomers as well as aminodinitrotoluene isomers. The explosive‐related compounds: 2,4‐dinitrotoluene (2,4‐DNT), 2,6‐dinitrotoluene (2,6‐DNT), 2‐amino‐4,6‐dinitrotoluene (2A‐4,6‐DNT) and 4‐amino‐2,6‐dinitrotoluene (4A‐2,6‐DNT) were analyzed by ESI‐MS in the negative ion mode; they produced mainly deprotonated molecules [M ? H]^?. Subsequent low resolution MSⁿ experiments provided support for fragment ion assignments and determination of consecutive dissociation pathways. Resonant activation of deprotonated dinitrotoluene isomers gave different fragment ions according to the position of the nitro and amino groups on the toluene backbone. Fragment ion identification was bolstered by accurate mass measurements performed using Fourier transform ion cyclotron resonance mass spectrometry (FT‐ICR/MS). Notably, unexpected results were found from accurate mass measurements performed at high resolution for 2,6‐DNT where a 30‐Da loss was observed that corresponds to CH₂O departure instead of the expected isobaric NO^? loss. Moreover, 2,4‐DNT showed a diagnostic fragment ion at m/z 116, allowing the unambiguous distinction between 2,4‐ and 2,6‐DNT isomers. Here, CH₂O loss is hindered by the presence of an amino group in both 2A‐4,6‐DNT and 4A‐2,6‐DNT isomers, but nevertheless, these isomers showed significant differences in their fragmentation sequences, thus allowing their differentiation. DFT calculations were also performed to support experimental observations. Copyright © 2014 John Wiley & Sons, Ltd.     

Intermolecular stacking in pyrazolo[3,4‐d]pyrimidine‐based pentamethylene‐linked flexible ­molecules

The crystal structures of 1‐{5‐[4,6‐bis­(methyl­sulfanyl)‐2H‐py­razolo­[3,4‐d]­pyrimidin‐2‐yl]­pentyl}‐6‐methyl­sulfanyl‐4‐(pyr­rolidin‐1‐yl)‐1H‐pyrazolo­[3,4‐d]­pyrimidine, C₂₂H₂₉N₉S₃, and 6‐methyl­sulfanyl‐1‐{5‐[6‐methyl­sulfanyl‐4‐(pyrrolidin‐1‐yl)‐2H‐pyrazolo­[3,4‐d]­pyrimidin‐2‐yl]­pentyl}‐4‐(pyrrolidin‐1‐yl)‐1H‐pyrazolo­[3,4‐d]­pyrimidine, C₂₅H₃₄N₁₀S₂, which differ in having either a pyrrolidine substituent or a methylsulfanyl group, show intermolecular stacking due to aromatic π–π interactions between the pyrazolo­[3,4‐d]­pyrimidine rings.     

Synthesis and characterization of two isostructural 3d–4f coordination compounds based on pyridine‐2,6‐dicarboxylic acid and 4,4′‐bipyridine

The design and synthesis of 3d–4f heterometallic coordination polymers have attracted much interest due to the intriguing diversity of their architectures and topologies. Pyridine‐2,6‐dicarboxylic acid (H₂pydc) has a versatile coordination mode and has been used to construct multinuclear and heterometallic compounds. Two isostructural centrosymmetric 3d–4f coordination compounds constructed from pyridine‐2,6‐dicarboxylic acid and 4,4′‐bipyridine (bpy), namely 4,4′‐bipyridine‐1,1′‐diium diaquabis(μ₂‐pyridine‐2,6‐dicarboxylato)tetrakis(pyridine‐2,6‐dicarboxylato)bis[4‐(pyridin‐4‐yl)pyridinium]cobalt(II)dieuropium(III) octahydrate, (C₁₀H₁₀N₂)[CoEu₂(C₁₀H₉N₂)₂(C₇H₃NO₄)₆(H₂O)₂]·8H₂O, (I), and 4,4′‐bipyridine‐1,1′‐diium diaquabis(μ₂‐pyridine‐2,6‐dicarboxylato)tetrakis(pyridine‐2,6‐dicarboxylato)bis[4‐(pyridin‐4‐yl)pyridinium]cobalt(II)diterbium(III) octahydrate, (C₁₀H₁₀N₂)[CoTb₂(C₁₀H₉N₂)₂(C₇H₃NO₄)₆(H₂O)₂]·8H₂O, (II), were synthesized under hydrothermal conditions and characterized by IR and fluorescence spectroscopy, thermogravimetric analysis and powder X‐ray diffraction. Both compounds crystallize in the triclinic space group P. The Eu^III and Tb^III cations adopt nine‐coordinated distorted tricapped trigonal–prismatic geometries bridged by three pydc^2? ligands. The Co^II cation has a six‐coordination environment formed by two pydc^2? ligands, two bpy ligands and two coordinated water molecules. Adjacent molecules are connected by π–π stacking interactions to form a one‐dimensional chain, which is further extended into a three‐dimensional supramolecular network by multipoint hydrogen bonds.     

Pseudopolymorphs of 2,6‐diaminopyrimidin‐4‐one and 2‐amino‐6‐methylpyrimidin‐4‐one: one or two tautomers present in the same crystal

The derivatives of pyrimidin‐4‐one can adopt either a 1H‐ or a 3H‐tautomeric form, which affects the hydrogen‐bonding interactions in cocrystals with compounds containing complementary functional groups. In order to study their tautomeric preferences, we crystallized 2,6‐diaminopyrimidin‐4‐one and 2‐amino‐6‐methylpyrimidin‐4‐one. During various crystallization attempts, four structures of 2,6‐diaminopyrimidin‐4‐one were obtained, namely solvent‐free 2,6‐diaminopyrimidin‐4‐one, C₄H₆N₄O, (I), 2,6‐diaminopyrimidin‐4‐one–dimethylformamide–water (3/4/1), C₄H₆N₄O·1.33C₃H₇NO·0.33H₂O, (Ia), 2,6‐diaminopyrimidin‐4‐one dimethylacetamide monosolvate, C₄H₆N₄O·C₄H₉NO, (Ib), and 2,6‐diaminopyrimidin‐4‐one–N‐methylpyrrolidin‐2‐one (3/2), C₄H₆N₄O·1.5C₅H₉NO, (Ic). The 2,6‐diaminopyrimidin‐4‐one molecules exist only as 3H‐tautomers. They form ribbons characterized by R²₂(8) hydrogen‐bonding interactions, which are further connected to form three‐dimensional networks. An intermolecular N—H...N interaction between amine groups is observed only in (I). This might be the reason for the pyramidalization of the amine group. Crystallization experiments on 2‐amino‐6‐methylpyrimidin‐4‐one yielded two isostructural pseudopolymorphs, namely 2‐amino‐6‐methylpyrimidin‐4(3H)‐one–2‐amino‐6‐methylpyrimidin‐4(1H)‐one–dimethylacetamide (1/1/1), C₅H₇N₃O·C₅H₇N₃O·C₄H₉NO, (IIa), and 2‐amino‐6‐methylpyrimidin‐4(3H)‐one–2‐amino‐6‐methylpyrimidin‐4(1H)‐one–N‐methylpyrrolidin‐2‐one (1/1/1), C₅H₇N₃O·C₅H₇N₃O·C₅H₉NO, (IIb). In both structures, a 1:1 mixture of 1H‐ and 3H‐tautomers is present, which are linked by three hydrogen bonds similar to a Watson–Crick C–G base pair.     

A convenient synthesis of pyrazolo[3,4‐d]pyrimidine‐4,6‐dione and pyrazolo[4,3‐d]pyrimidine‐5,7‐dione derivatives

Pyrazolo‐[3,4‐d]pyrimidine‐4,6‐diones 5 and pyrazolo[4,3‐d]pyrimidine‐5,7‐diones 7 were synthesized by Curtius rearrangement of pyrazolic mono‐esters 2 and 3 followed by hetero‐cyclization via the ureas derivatives 4 and 6 under alkaline conditions.     

Five pseudopolymorphs and a cocrystal of nitrofurantoin

The antibiotic nitrofurantoin {systematic name: (E)‐1‐[(5‐nitro‐2‐furyl)methylideneamino]imidazolidine‐2,4‐dione} is not only used for the treatment of urinary tract infections, but also illegally applied as an animal food additive. Since derivatives of 2,6‐diaminopyridine might serve as artificial receptors for its recognition, we crystallized one potential drug–receptor complex, nitrofurantoin–2,6‐diacetamidopyridine (1/1), C₈H₆N₄O₅·C₉H₁₁N₃O₂, (I·II). It is characterized by one N—H...N and two N—H...O hydrogen bonds and confirms a previous NMR study. During the crystallization screening, several new pseudopolymorphs of both components were obtained, namely a nitrofurantoin dimethyl sulfoxide monosolvate, C₈H₆N₄O₅·C₂H₆OS, (Ia), a nitrofurantoin dimethyl sulfoxide hemisolvate, C₈H₆N₄O₅·0.5C₂H₆OS, (Ib), two nitrofurantoin dimethylacetamide monosolvates, C₈H₆N₄O₅·C₄H₉NO, (Ic) and (Id), and a nitrofurantoin dimethylacetamide disolvate, C₈H₆N₄O₅·2C₄H₉NO, (Ie), as well as a 2,6‐diacetamidopyridine dimethylformamide monosolvate, C₉H₁₁N₃O₂·C₃H₇NO, (IIa). Of these, (Ia), (Ic) and (Id) were formed during cocrystallization attempts with 1‐(4‐fluorophenyl)biguanide hydrochloride. Obviously nitrofurantoin prefers the higher‐energy conformation in the crystal structures, which all exhibit N—H...O and C—H...O hydrogen‐bond interactions. The latter are especially important for the crystal packing. 2,6‐Diacetamidopyridine shows some conformational flexibility depending on the hydrogen‐bond pattern.     

Design of two series of 1:1 cocrystals involving 4‐amino‐5‐chloro‐2,6‐dimethylpyrimidine and carboxylic acids

Two series of a total of ten cocrystals involving 4‐amino‐5‐chloro‐2,6‐dimethylpyrimidine with various carboxylic acids have been prepared and characterized by single‐crystal X‐ray diffraction. The pyrimidine unit used for the cocrystals offers two ring N atoms (positions N1 and N3) as proton‐accepting sites. Depending upon the site of protonation, two types of cations are possible [Rajam et al. (2017). Acta Cryst. C 73 , 862–868]. In a parallel arrangement, two series of cocrystals are possible depending upon the hydrogen bonding of the carboxyl group with position N1 or N3. In one series of cocrystals, i.e. 4‐amino‐5‐chloro‐2,6‐dimethylpyrimidine–3‐bromothiophene‐2‐carboxylic acid (1/1), 1 , 4‐amino‐5‐chloro‐2,6‐dimethylpyrimidine–5‐chlorothiophene‐2‐carboxylic acid (1/1), 2 , 4‐amino‐5‐chloro‐2,6‐dimethylpyrimidine–2,4‐dichlorobenzoic acid (1/1), 3 , and 4‐amino‐5‐chloro‐2,6‐dimethylpyrimidine–2‐aminobenzoic acid (1/1), 4 , the carboxyl hydroxy group (–OH) is hydrogen bonded to position N1 (O—H…N1) of the corresponding pyrimidine unit (single point supramolecular synthon). The inversion‐related stacked pyrimidines are doubly bridged by the carboxyl groups via N—H…O and O—H…N hydrogen bonds to form a large cage‐like tetrameric unit with an R₄²(20) graph‐set ring motif. These tetrameric units are further connected via base pairing through a pair of N—H…N hydrogen bonds, generating R₂²(8) motifs (supramolecular homosynthon). In the other series of cocrystals, i.e. 4‐amino‐5‐chloro‐2,6‐dimethylpyrimidine–5‐methylthiophene‐2‐carboxylic acid (1/1), 5 , 4‐amino‐5‐chloro‐2,6‐dimethylpyrimidine–benzoic acid (1/1), 6 , 4‐amino‐5‐chloro‐2,6‐dimethylpyrimidine–2‐methylbenzoic acid (1/1), 7 , 4‐amino‐5‐chloro‐2,6‐dimethylpyrimidine–3‐methylbenzoic acid (1/1), 8 , 4‐amino‐5‐chloro‐2,6‐dimethylpyrimidine–4‐methylbenzoic acid (1/1), 9 , and 4‐amino‐5‐chloro‐2,6‐dimethylpyrimidine–4‐aminobenzoic acid (1/1), 10 , the carboxyl group interacts with position N3 and the adjacent 4‐amino group of the corresponding pyrimidine ring via O—H…N and N—H…O hydrogen bonds to generate the robust R₂²(8) supramolecular heterosynthon. These heterosynthons are further connected by N—H…N hydrogen‐bond interactions in a linear fashion to form a chain‐like arrangement. In cocrystal 1 , a Br…Br halogen bond is present, in cocrystals 2 and 3 , Cl…Cl halogen bonds are present, and in cocrystals 5 , 6 and 7 , Cl…O halogen bonds are present. In all of the ten cocrystals, π–π stacking interactions are observed.     

Nonclassical Pschorr and Sandmeyer Reactions in Pyrazole Series

The diazonium salt derived from 4‐amino‐N,1,3‐trimethyl‐N‐(3‐methyl‐1‐phenyl‐1H‐pyrazol‐5‐yl)‐1H‐pyrazole‐5‐carboxamide ( 14 ) was reacted with a mixture of CuSO₄ and NaCl, with ascorbic acid as an initiator to afford the planar derivative 4,6‐dihydro‐1,4,6,8‐tetramethyl‐3‐phenyldipyrazolo[3,4‐b:4′,3′‐d]pyridin‐5(3H)‐one ( 16 ) and its unexpected isomer 4,6‐dihydro‐3,4,6,8‐tetramethyl‐1‐phenyldipyrazolo[4,3‐b:4′,3′‐d]pyridin‐5(1H)‐one ( 17 ), as well as the epimers (3S,4S)‐ (or (3S,4R)‐) and (3S,4R)‐ (or (3S,4S)‐) 4‐chloro‐2,4‐dihydro‐1′,3′,5,5′‐tetramethyl‐2‐phenylspiro[pyrazole‐3,4′(1′H)‐pyrrolo[3,4‐c]pyrazol]‐6′(5′H)‐one ( 18a and b , respectively). Epimers 18a and b were converted under basic conditions to 4′‐chloro‐N,1,3,3′‐tetramethyl‐1′‐phenyl‐[4,5′‐bi‐1H‐pyrazole]‐5‐carboxamide ( 19 ). The structures of isomers 16 and 17 determined by single‐crystal X‐ray analysis are also reported. Linear dichroism (LD) measurements for the above isomers suggest that 17 intercalates into DNA, and 17 exhibited antiproliferation activity against human NCI‐H460 pulmonary carcinoma cells.     

Zn(NCS)2‐3‐cyanopyridine Coordination Compounds: Synthesis,Crystal Structures,and Thermal Properties

The reaction of different stoichiometric amounts of Zn(NCS)₂ with 3‐cyanopyridine in different solvents leads to the formation of several new coordination compounds, which were structurally characterized and investigated for their thermal behavior. In Zn(NCS)₂(3‐cyanopyridine)₄ ( 1 ) and Zn(NCS)₂(3‐cyanopyridine)₂(H₂O)₂ · (3‐cyanopyridine)₂ ( 2 ) the zinc cations are octahedrally coordinated by two terminally N‐bonded thiocyanate anions and four 3‐cyanopyridine ( 1 ) or two 3‐cyanopyridine and two water molecules ( 2 ) within slightly distorted octahedra. Zn(NCS)₂(3‐cyanopyridine)₂ ( 3 ) and Zn(NCS)₂(3‐cyanopyridine)₂ · (H₂O)_0.5 ( 3‐H₂O ) also form discrete complexes but with tetrahedrally coordinated Zn cations. Upon heating compound 1 decomposes without the formation of any intermediate compound. In contrast, compound 2 loses the water molecules in the first step and transforms into compound 1 . Surprisingly, upon further heating a second TG step is observed, in which compound 3 is formed as an intermediate, which is not observed if compound 1 is heated directly. The tetrahedral complex 3 melts leading to the formation of an amorphous phase. If the hemihydrate 3‐H₂O is heated, it transforms into 3 via melting and crystallization but there are hints that a metastable phase might form as intermediate on water removal.     

Cocrystals of 2,6‐dichloroaniline and 2,6‐dichlorophenol plus three new pseudopolymorphs of their coformers

The structures of cocrystals of 2,6‐dichlorophenol with 2,4‐diamino‐6‐methyl‐1,3,5‐triazine, C₆H₄Cl₂O·C₄H₇N₅, (III), and 2,6‐dichloroaniline with 2,6‐diaminopyrimidin‐4(3H)‐one and N,N‐dimethylacetamide, C₆H₅Cl₂N·C₄H₆N₄O·C₄H₉NO, (V), plus three new pseudopolymorphs of their coformers, namely 2,4‐diamino‐6‐methyl‐1,3,5‐triazine–N,N‐dimethylacetamide (1/1), C₄H₇N₅·C₄H₉NO, (I), 2,4‐diamino‐6‐methyl‐1,3,5‐triazine–N‐methylpyrrolidin‐2‐one (1/1), C₄H₇N₅·C₅H₉NO, (II), and 6‐aminoisocytosine–N‐methylpyrrolidin‐2‐one (1/1), C₄H₆N₄O·C₅H₉NO, (IV), are reported. Both 2,6‐dichlorophenol and 2,6‐dichloroaniline are capable of forming definite synthon motifs, which usually lead to either two‐ or three‐dimensional crystal‐packing arrangements. Thus, the two isomorphous pseudopolymorphs of 2,4‐diamino‐6‐methyl‐1,3,5‐triazine, i.e. (I) and (II), form a three‐dimensional network, while the N‐methylpyrrolidin‐2‐one solvate of 6‐aminoisocytosine, i.e. (IV), displays two‐dimensional layers. On the basis of these results, attempts to cocrystallize 2,6‐dichlorophenol with 2,4‐diamino‐6‐methyl‐1,3,5‐triazine, (III), and 2,6‐dichloroaniline with 6‐aminoisocytosine, (V), yielded two‐dimensional networks, whereby in cocrystal (III) the overall structure is a consequence of the interaction between the two compounds. By comparison, cocrystal–solvate (V) is mainly built by 6‐aminoisocytosine forming layers, with 2,6‐dichloroaniline and the solvent molecules arranged between the layers.